Jamie L. Reynoso

CIK 1839066 · CEO, Medicare Advantage · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.48M

Companies

2

Total Filings

62

Lifetime Open-Market Net

-$385.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CLOV CEO, Medicare Advantage 2,849,921 $4.73 $13.48M -$385.6K 60 2026-06-11
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOVW) Delisted Chief Operating Officer 220,820 $2.02 $446.1K $0 2 2021-07-20

Recent Filings · Page 5 of 7

62 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-18 CLOV Tax (F) −13,154 -$14.3K EDGAR
2024-04-05 CLOV Tax (F) −5,387 -$4.1K EDGAR
2024-03-19 CLOV Tax (F) −5,378 -$4.3K EDGAR
2024-03-18 CLOV Tax (F) −7,777 -$5.7K EDGAR
2024-01-09 CLOV Tax (F) −16,369 -$15.6K EDGAR
2024-01-05 CLOV Tax (F) −26,240 -$24.1K EDGAR
2024-01-03 CLOV Grant (A) +652,566 $0 EDGAR
2024-01-03 CLOV Tax (F) −1,559 -$1.5K EDGAR
2023-12-19 CLOV Tax (F) −8,691 -$8.6K EDGAR
2023-12-18 CLOV Tax (F) −12,567 -$12.6K EDGAR
Showing 4150 of 62
Page 5 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.